M&R CAPITAL MANAGEMENT INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 303 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
M&R CAPITAL MANAGEMENT INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2021$25,000
-7.4%
1,5090.0%0.01%
-14.3%
Q1 2021$27,0000.0%1,5090.0%0.01%
+16.7%
Q4 2020$27,000
-22.9%
1,509
-25.0%
0.01%
-33.3%
Q3 2020$35,000
-2.8%
2,0120.0%0.01%
-10.0%
Q2 2020$36,000
+20.0%
2,0120.0%0.01%
+11.1%
Q1 2020$30,000
-33.3%
2,012
-12.6%
0.01%
-10.0%
Q4 2019$45,000
+15.4%
2,3030.0%0.01%
+11.1%
Q3 2019$39,000
-9.3%
2,303
-6.9%
0.01%
-10.0%
Q2 2019$43,000
+7.5%
2,474
+13.6%
0.01%
+11.1%
Q1 2019$40,0002,1770.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders